GlassScriptPhysician profile
Lindsay Smith
NPI 1699002485
$12,354.04
in general payments reported to CMS, 2019-2025
26 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,348 · 2022: $2,071 · 2023: $4,432 · 2024: $3,292 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,941 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100 · Travel and Lodging: $1,802 · Education: $92.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,941.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
| Travel and Lodging | $1,801.83 |
| Education | $92.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,708.43 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $1,023.36 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $834.44 | 2021-2022 | |
| Astellas Pharma US INC | $615.17 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $611.58 | 2021-2024 | |
| Amgen INC. | $588.35 | 2021-2025 | Evenity, Prolia, Prolia |
| Agile Therapeutics, INC. | $516.40 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $451.66 | 2023-2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $427.02 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $403.68 | 2021-2025 | |
| Radius Health, INC. | $376.98 | 2021-2025 | Tymlos |
| Evofem Biosciences, INC. | $242.52 | 2021-2023 | Phexxi |
| Organon LLC | $176.99 | 2023-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $156.51 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.99 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $138.50 | 2021-2025 | Femring, Intrarosa, Femlyv |
| Therapeuticsmd, INC. | $133.43 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $121.84 | 2023 | Quviviq |
| Myriad Women'S Health, INC. | $110.39 | 2023 | Myrisk |
| Merck Sharp & Dohme LLC | $109.92 | 2021-2025 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $108.08 | 2021-2024 | Thinprep 2000 Processor |
| Revance Therapeutics, INC. | $106.59 | 2025 | Daxxify |
| Scynexis, INC. | $92.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.31 | 2025 | |
| Virtus Pharmaceuticals LLC | $48.35 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $34.42 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.